Kaisa Huhtinen
PhD, Adjunct Professor in Cancer Biology
kaisa.huhtinen@utu.fi +358 29 450 2645 +358 50 572 6733 Kiinamyllynkatu 10 Turku Office: D5038 ORCID identifier: https://orcid.org/0000-0001-9685-5246 |
Areas of expertise
Ovarian cancer; personalized medicine; early diagnostics; prediction; prognosis; biomarker; genomics; drug target; interdicipline research;
Ovarian cancer; personalized medicine; early diagnostics; prediction; prognosis; biomarker; genomics; drug target; interdicipline research;
Biography
Research
Publications 
2 of 8
- Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma (2023)
- Biomedicine and Pharmacotherapy
(A1 Refereed original research article in a scientific journal) - Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma (2023)
- Cancer Cell
(A1 Refereed original research article in a scientific journal) - Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis (2023)
- STAR protocols
(A1 Refereed original research article in a scientific journal) - Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer (2023)
- Basic and Clinical Pharmacology and Toxicology
(A1 Refereed original research article in a scientific journal) - Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer (2022)
- International Journal of Cancer
(A1 Refereed original research article in a scientific journal) - Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids (2022)
- Gynecologic Oncology
(A1 Refereed original research article in a scientific journal) - Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status (2022)
- Frontiers in Oncology
(A1 Refereed original research article in a scientific journal) - Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer (2022)
- Science Advances
(A1 Refereed original research article in a scientific journal) - Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype (2022)
- Molecular Cancer Therapeutics
(A1 Refereed original research article in a scientific journal) - QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability (2022)
- Laboratory Investigation
(A1 Refereed original research article in a scientific journal)
UTU Research Portal